Clinical Trials Directory

Trials / Conditions / Head and Neck Squamous Cell Cancer

Head and Neck Squamous Cell Cancer

23 registered clinical trials studyying Head and Neck Squamous Cell Cancer — 6 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingA Single Arm Phase II Trial in p16-positive Oropharynx Cancer of Selective Dose De-escalation of nodAl VolumEs
NCT07418034
University of Maryland, BaltimorePhase 2
RecruitingA Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC
NCT07462377
EpiBiologicsPhase 1
Enrolling By InvitationA Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid T
NCT07218003
Rondo TherapeuticsPhase 1
RecruitingA Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With S
NCT06682793
A2 Biotherapeutics Inc.Phase 1 / Phase 2
RecruitingIntratumoral Delivery of Viral Replicon (saRNA) Particles Expressing IL-12 in Head and Neck Cancer
NCT06736379
VLP TherapeuticsPhase 1
RecruitingStudy of XB010 in Subjects With Solid Tumors
NCT06545331
ExelixisPhase 1
UnknownA Study of Toripalimab Injection (JS001) + Cetuximab in Treatment of Advanced Head and Neck Squamous Cell Canc
NCT04856631
Shanghai Junshi Bioscience Co., Ltd.Phase 1 / Phase 2
TerminatedLITT and Pembrolizumab in Recurrent Brain Metastasis
NCT04187872
University of FloridaPhase 1
UnknownSintilimab in Combination With Nab-paclitaxel in Patients With HNSCC (Head and Neck Squamous Cell Carcinoma )
NCT03975270
Shengyu ZhouPhase 2
CompletedCabozantinib in Combination With Cetuximab in Patients With Recurrent or Metastatic Head and Neck Squamous Cel
NCT03667482
Memorial Sloan Kettering Cancer CenterPhase 1
CompletedA Window of Opportunity Study to Assess the Modulation of Biomarkers in Head and Neck Squamous Cell Cancer (HN
NCT03138070
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sN/A
UnknownCisplatin Plus Raltitrexed or 5-fluorouracil Concurrent With Radiotherapy for Head and Neck Squamous Cell Canc
NCT02485548
Jiangsu Cancer Institute & HospitalPhase 3
CompletedPembrolizumab (MK-3475) Versus Standard Treatment for Recurrent or Metastatic Head and Neck Cancer (MK-3475-04
NCT02252042
Merck Sharp & Dohme LLCPhase 3
CompletedCetuximab + BYL719 + IMRT (Intensity-Modulated Radiation Therapy) in Stage III/IVB Head and Neck Squamous Cell
NCT02282371
Memorial Sloan Kettering Cancer CenterPhase 1
CompletedStudy of HPV Specific Immunotherapy in Participants With HPV Associated Head and Neck Squamous Cell Carcinoma
NCT02163057
Inovio PharmaceuticalsPhase 1 / Phase 2
CompletedPilot Study of Metformin in Head and Neck Squamous Cell Cancer and Its Effects on Stromal-epithelial Metabolic
NCT02083692
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityEARLY_Phase 1
TerminatedUse of Pharmacogenetics to Select Erbitux or Cisplatin to Treat Head and Neck Cancer
NCT01790516
Georgetown UniversityN/A
CompletedA Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands
NCT01351103
Novartis PharmaceuticalsPhase 1
TerminatedInduction Chemo Then Concurrent Chemoradiotherapy With Cetuximab in Locally Advanced Head and Neck Squamous Ce
NCT01326923
Louisiana State University Health Sciences Center ShreveportPhase 2
CompletedSafety Study of Modified Vaccinia Virus to Cancer
NCT00574977
David BartlettPhase 1
UnknownIntensive Nutrition Counselling in Patients With Head and Neck Cancer
NCT02159508
Helsinki University Central HospitalN/A
CompletedHead and Neck Cancer Screening and Serum Repository
NCT00592371
University of Arkansas—
TerminatedLIFE-Lung Bronchoscopy in Patients at Risk for Developing Lung Cancer
NCT00260598
University of PittsburghPhase 2